Asthma Medication Market

List of Tables
Table 1. Asthma Medication CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Asthma Medication Market Trends
Table 3. Asthma Medication Market Drivers
Table 4. Asthma Medication Market Challenges
Table 5. Asthma Medication Market Restraints
Table 6. Global Asthma Medication Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Asthma Medication Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Asthma Medication Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Asthma Medication Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Asthma Medication Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Asthma Medication Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Asthma Medication Revenue Share by Manufacturer, 2017-2022
Table 13. Global Asthma Medication Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Asthma Medication Sales Share by Manufacturer, 2017-2022
Table 15. Global Asthma Medication Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Asthma Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Asthma Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Medication as of 2021)
Table 18. Top Players of Asthma Medication in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Asthma Medication Product Type
Table 20. Date of International Manufacturers Enter into Asthma Medication Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Asthma Medication Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Asthma Medication Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Asthma Medication Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Asthma Medication Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Asthma Medication Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Asthma Medication Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Asthma Medication Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Asthma Medication Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Asthma Medication Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Asthma Medication Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Asthma Medication Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Asthma Medication Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Asthma Medication Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Asthma Medication Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Asthma Medication Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Asthma Medication Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Asthma Medication Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Asthma Medication Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Asthma Medication Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Asthma Medication Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Dulera Corporation Information
Table 43. Dulera Description and Business Overview
Table 44. Dulera Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Dulera Asthma Medication Product
Table 46. Dulera Recent Development
Table 47. QVAR Corporation Information
Table 48. QVAR Description and Business Overview
Table 49. QVAR Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. QVAR Product
Table 51. QVAR Recent Development
Table 52. Glaxosmithkline plc Corporation Information
Table 53. Glaxosmithkline plc Description and Business Overview
Table 54. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Glaxosmithkline plc Product
Table 56. Glaxosmithkline plc Recent Development
Table 57. MAP Pharmaceuticals?Inc Corporation Information
Table 58. MAP Pharmaceuticals?Inc Description and Business Overview
Table 59. MAP Pharmaceuticals?Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. MAP Pharmaceuticals?Inc Product
Table 61. MAP Pharmaceuticals?Inc Recent Development
Table 62. Merck & Co. Inc Corporation Information
Table 63. Merck & Co. Inc Description and Business Overview
Table 64. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Merck & Co. Inc Product
Table 66. Merck & Co. Inc Recent Development
Table 67. AstraZeneca plc Corporation Information
Table 68. AstraZeneca plc Description and Business Overview
Table 69. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. AstraZeneca plc Product
Table 71. AstraZeneca plc Recent Development
Table 72. Roche Holdings Ltd Corporation Information
Table 73. Roche Holdings Ltd Description and Business Overview
Table 74. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Roche Holdings Ltd Product
Table 76. Roche Holdings Ltd Recent Development
Table 77. Genentech Inc Corporation Information
Table 78. Genentech Inc Description and Business Overview
Table 79. Genentech Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Genentech Inc Product
Table 81. Genentech Inc Recent Development
Table 82. Sepracor, Inc Corporation Information
Table 83. Sepracor, Inc Description and Business Overview
Table 84. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Sepracor, Inc Product
Table 86. Sepracor, Inc Recent Development
Table 87. Schering-Plough Corp Corporation Information
Table 88. Schering-Plough Corp Description and Business Overview
Table 89. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Schering-Plough Corp Product
Table 91. Schering-Plough Corp Recent Development
Table 92. Sanofi-Aventis Corporation Information
Table 93. Sanofi-Aventis Description and Business Overview
Table 94. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Sanofi-Aventis Product
Table 96. Sanofi-Aventis Recent Development
Table 97. Theravance Inc Corporation Information
Table 98. Theravance Inc Description and Business Overview
Table 99. Theravance Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Theravance Inc Product
Table 101. Theravance Inc Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Asthma Medication Customers List
Table 105. Asthma Medication Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma Medication Product Picture
Figure 2. Global Asthma Medication Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Asthma Medication Market Size 2017-2028 (US$ Million)
Figure 4. Global Asthma Medication Sales 2017-2028 (K Units)
Figure 5. United States Asthma Medication Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Asthma Medication Market Size 2017-2028 (US$ Million)
Figure 7. United States Asthma Medication Sales 2017-2028 (K Units)
Figure 8. United States Asthma Medication Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Asthma Medication Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Asthma Medication Report Years Considered
Figure 11. Product Picture of Quick-Relief Medications
Figure 12. Product Picture of Long-Term Control Medications
Figure 13. Product Picture of Asthma Medications During Pregnancy
Figure 14. Global Asthma Medication Market Share by Type in 2022 & 2028
Figure 15. Global Asthma Medication Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Asthma Medication Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Asthma Medication Sales by Type (2017-2028) & (K Units)
Figure 18. Global Asthma Medication Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Asthma Medication Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Asthma Medication Market Share by Type in 2022 & 2028
Figure 21. United States Asthma Medication Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Asthma Medication Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Asthma Medication Sales by Type (2017-2028) & (K Units)
Figure 24. United States Asthma Medication Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Asthma Medication Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Children
Figure 27. Product Picture of Adolescent
Figure 28. Product Picture of Adult
Figure 29. Global Asthma Medication Market Share by Application in 2022 & 2028
Figure 30. Global Asthma Medication Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Asthma Medication Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Asthma Medication Sales by Application (2017-2028) & (K Units)
Figure 33. Global Asthma Medication Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Asthma Medication Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Asthma Medication Market Share by Application in 2022 & 2028
Figure 36. United States Asthma Medication Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Asthma Medication Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Asthma Medication Sales by Application (2017-2028) & (K Units)
Figure 39. United States Asthma Medication Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Asthma Medication Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Asthma Medication Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Asthma Medication Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Asthma Medication Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Asthma Medication Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Asthma Medication Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Asthma Medication Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Asthma Medication Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Asthma Medication Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Asthma Medication Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Asthma Medication Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Asthma Medication Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Asthma Medication Value Chain
Figure 75. Asthma Medication Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed